Mumbai: Zuventus Healthcare Limited, a leading Indian pharmaceutical company founded in 2002 and a subsidiary of Emcure Pharmaceuticals (listed on the BSE and NSE), has issued a formal clarification to address and dismiss false and misleading communications regarding the company’s future. Zuventus categorically denies rumors of closure or rebranding. Zuventus further clarifies that there has been no closure, suspension, or transfer of its business assets, and that its field staff continues to operate at full strength across the country.
Zuventus clarifies that it has no association or affiliation with any entity named – Zorvia Healthcare Limited and reiterates that such claims are inaccurate and misleading.
Zuventus is committed towards its responsibility of developing, manufacturing and marketing high-quality and affordable medicines to its stakeholders. The company is actively pursuing appropriate legal remedies under the law to protect its goodwill, amongst its stakeholders.
